Jagsonpal Pharmaceuticals Limited has entered into an agreement with Suvinys Developers Private Limited for the Supply of Product Dydrogesterone.

Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.

The company last week reported a total income of Rs56.4275 crore during the period ended December 31, 2021, as compared to Rs.57.6391 crore during the period ended December 31, 2020.

It posted a net profit of Rs5.4065 crore for the period ended December 31, 2021, as against a net profit of Rs5.4303 crore for the period ended December 31, 2020.